◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
Takeda Pharmaceutical Company Limited — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemQ4 2025Oct 30, 2025Q4 2024Oct 31, 2024Q1 2024Mar 31, 2024Q1 2023Mar 31, 2023Q1 2022Mar 31, 2022Q1 2021Mar 31, 2021
+Operating Income 350.6B 119.2B -- -- -- --
Operating Margin % 137.0% 305.3% -- -- -- --
+Ordinary Income 256.0B 39.1B -- -- -- --
Revenue Growth % 555.5% -- -- -- -- --
Line ItemQ4 2025Oct 30, 2025Q4 2024Oct 31, 2024Q1 2024Mar 31, 2024Q1 2023Mar 31, 2023Q1 2022Mar 31, 2022Q1 2021Mar 31, 2021
Current Assets 2521.2B 2558.6B -- -- -- --
Total Assets 14248.3B 15108.8B 14792.7B 14065.4B 12560.3B 12286.1B
Total Liabilities 7312.4B 7834.8B 7871.1B 7748.0B 7235.9B 7646.7B
Total Equity 6936.0B 7274.0B 6921.7B 6317.4B 5324.4B 4639.4B
No data available for this statement.
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...